Breaking News
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
The Human Microbiome – A New Potential Fingerprint in Forensic Evidence?

The Human Microbiome – A New Potential Fingerprint in Forensic Evidence?

image_pdfDownload PDFimage_print

An interview with Professor Jack Gilbert, conducted by Alina Shrourou, BSc.

What is a microbiome and why are microbiomes unique to an individual?

A microbiome is the sum total of the microbes of bacteria, fungi, and viruses that live inside your body. They are all over your skin and in your gut. Bacteria alone accounts for 2-3 lbs of your body mass.

© vrx/Shutterstock.com

What’s interesting is that when you’re born, you’re mostly sterile. You acquire microbes from your mother and the environment. Then, the way you live your life and the things you interact with shape the kind of microbes that colonize and live inside you. This results in your own unique profile, and even identical twins have different profiles.

Please outline the Burglary Microbiome Project that you discussed at Pittcon 2018.

We’ve been trying to understand if our bacterial signature can act like a fingerprint, and be used as some kind of forensic tool, like trace evidence.

We emit around 36 million bacterial cells into our immediate environment every single hour – so if a burglar in a room for 10 minutes touches objects and leaves behind some their bacteria, can we detect their personal bacterial signature by obtaining some of the bacteria present in the room?

It could then be possible to sequence the information, as we do with human DNA at a crime scene, and therefore identify that individual.

It’s an interesting idea, and at the moment it’s a very early research project that we’re working on with the National Institute of Justice.

How do you determine whether a microbial organism is associated with a particular trait?

We’ve been trying to see if the bacterial signature that lives inside us is somehow correlated with our lifestyle choices.

The signature that belongs to you is very much determined by how you’ve lived your life; whether you had pets growing up, whether you grew up in a city or a farm etc, are all factored in.

Different working environments can determine what bacteria live inside you, how they grow and how they’re distributed, so we wanted to see if that correlates. We built up a database of over 12,000 people and we’ve been correlating how similar our mock burglars microbiome signatures are to people in our database. It’s complicated, but we’re getting really close to identifying somebody’s lifestyle traits based on the microbial signature they leave behind at a crime scene.

What analytical techniques are you using to identify microbial biomarkers?

We leverage genome sequencing, especially the Illumina platforms – DNA extraction, and PCR amplification, much the same way as we would with human DNA sequences. We identify a particular gene present in all bacteria which we then sequence and use to determine which bacterial organisms are present in different subjects and what makes an individual unique.

We then produce a probability estimate that your bacteria would be found in a certain environment. Using advanced statistical techniques, we try and identify whether your bacteria’s sequencing data can place you at that crime scene.

Please outline any specific biomarkers that you have already identified in this project.

The way in which we analyze the microbiota is by looking for unique strains of organisms. We all have one particular species of E. coli living inside our gut, and we all have Staphylococcus epidermidis living in our skin, but each individual has a strain with a genotype and genome unique to them. It evolves with you and mutates over time, and we call those mutations biomarkers.

We’re using that information to try and identify whether we can pull out particular genotypic mutations, or biomarkers, which are unique to an individual.

If an individual’s lifestyle can change throughout their lifetime, does this mean that their microbiome can too? If so, are microbiome signatures always an accurate identification tool?

We are trying to answer a very particular question; whether the microbiome profile of an individual is stable and stays with you throughout your life.

We hypothesize based on all the data we’ve collected that we have a unique strain based composition which is a fingerprint of our microbiota, but we haven’t proved this, and there are lots of factors that could alter this theory.

Part of this project is to try and identify whether our microbial fingerprint stable, and how stable it is. Once you leave a trace of your bacteria signature on a doorknob or television set, does it decay? And if so, how rapidly?

What do you think the future holds for using an individual’s unique microbiome in this way? Or for other applications?

The future is really exciting. We can potentially use the microbiome in forensic science, but that would be in the distant future. The human DNA program for forensic evidence took decades, and we’re only just starting our journey.

What’s most exciting is we can also use the microbiome information inside our bodies in personalized medicine, using the microbiome to predict whether an individual will respond to a particular therapy.

We could screen a cancer patient’s microbiome and determine if they have the biomarkers that can indicate their response to immunotherapy, which can help health care professionals identify their ideal strategy for therapy. We can use this to tailor treatment to the individual rather than the average treatment of a population.

How can Pittcon 2018 help you with your research?

What’s exciting about Pittcon is that it brings together a whole group of technological experts in areas that I wouldn’t normally have access to.

Being able to access the breadth of experience and technologies that are available to me here gives me more opportunities to expand my research objectives and to do something novel and exciting, that perhaps I wouldn’t normally have the chance to be involved in.

About Prof. Jack Gilbert

Professor Jack A Gilbert earned his Ph.D. from Unilever and Nottingham University, UK in 2002, and received his postdoctoral training at Queens University, Canada. He subsequently returned to the UK in 2005 to Plymouth Marine Laboratory at a senior scientist until his move to Argonne National Laboratory and the University of Chicago in 2010.

Currently, Professor Gilbert is the Director of the Microbiome Center and a Professor of Surgery at the University of Chicago. He is also Group Leader for Microbial Ecology at Argonne National Laboratory, Research Associate at the Field Museum of Natural History, Scientific Fellow at the Marine Biological Laboratory, and the Yeoh Ghim Seng Visiting Professorship in Surgery at the National University of Singapore.

Gilbert uses molecular analysis to test fundamental hypotheses in microbial ecology. He has authored more than 250 peer reviewed publications and book chapters on metagenomics and approaches to ecosystem ecology. He is the founding Editor in Chief of mSystems journal. In 2014 he was recognized on Crain’s Business Chicago’s 40 Under 40 List, and in 2015 he was listed as one of the 50 most influential scientists by Business Insider, and in the Brilliant Ten by Popular Scientist.

In 2016 he won the Altemeier Prize from the Surgical Infection Society, and the WH Pierce Prize from the Society for Applied Microbiology for research excellence. He also co-authored “Dirt is Good” published in 2017, a popular science guide to the microbiome and children’s health.

Tagged with:

About author

Related Articles